DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2023. “We delivered a positive start to the year across the organization and in particular, strong growth in revenues, volumes, and Adjusted EBITDA in our ambulatory care segment,” said Saum Sutaria, M.D., Chief Executive Officer of Tenet. “Our commitment to expanding access to high-quality, specialty care and maintaining our disciplined approach to managing oper
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of First Drug Candidate for Cannabis Use Disorder
- Flora Growth Corp. to Effect Reverse Stock Split
- Canopy Growth Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- Rapid Dose Announces Proposed Private Placement Financing
- Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
More from this user
